Results 171 to 180 of about 45,806 (246)

PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI™ healthcare database. [PDF]

BMC Nephrol
Uriol-Rivera MG, Ernst FR, Booth JN, Comas À, Gasteyger C, Tomazos I, Lum C, Wang Y, Ávila AI.   +8 more
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura [PDF]

Journal of Blood Disorders & Transfusion, 2013
Suzanne El-Sayegh, Pranab Sharma Acharya, Chadi Saifan, Suchita Mehta, Rabih Nasr   +4 more
openaire   +2 more sources

Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil. [PDF]

Appl Health Econ Health Policy
Simões Correa Galendi J, Rasch H, Caramori CA, Gaiolla RD, Müller D, Nogueira VSN.   +5 more
europepmc   +1 more source

The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. [PDF]

Orphanet J Rare Dis
Ma H, He Y, Li S, Yang Y, Huo L, Li T.
europepmc   +1 more source

Erratum for Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer. [PDF]

Intern Med
Yoshida Y, Toriyabe S, Imai H, Sasaki K, Kasahara Y, Ouchi K, Saijo K, Onodera K, Ishioka C.   +8 more
europepmc   +1 more source

From Common Symptom to Critical Diagnosis: Vertigo as a Clue to Thrombotic Thrombocytopenic Purpura. [PDF]

Cureus
Stern AJ, Munoz NR, Khan R, Agwuegbo CC, Yasin S, Pearson M, Gauhar F.   +6 more
europepmc   +1 more source

Delayed Recovery of a Disintegrin-Like and Metalloproteinase With Thrombospondin Type 1 Motif 13 (ADAMTS13) Activity in Immune Thrombotic Thrombocytopenic Purpura Treated With Caplacizumab and Rituximab. [PDF]

Cureus
Fujiwara Y, Okamoto M.
europepmc   +1 more source

SARS-CoV-2 Vaccination Can Only Be Held Responsible for Thrombotic Thrombocytopenic Purpura After All Differentials Have Been Ruled Out. [PDF]

HCA Healthc J Med
Finsterer J.
europepmc   +1 more source

A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab. [PDF]

Virol J
Yu B, Zhu Y, Jin Z, Han F, Lv F.
europepmc   +1 more source